Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Obama Highlights Health Care Reform Progress In Weekly Address
In his weekly radio and Internet address, President Obama discussed efforts by congressional leaders and health care industry groups on health care reform legislation, The Hill reports. He said that "while there remains a great deal of difficult work ahead, I am heartened by what we have seen these past few days: a willingness of those with different points of view and disparate interests to come together around common goals -- to embrace a shared sense of responsibility and make historic progress" (Youngman, The Hill, 5/16). He said, "I have always believed that it is better to talk than not to talk, that it is far more productive to reach over a divide than to shake your fist across it," which has "been an alien notion in Washington for far too long, but we are seeing that the ways of Washington are beginning to change."In the Republican radio and Internet address. Rep. Charles Boustany (R-La.), a cardiovascular surgeon, said that a "government takeover of health care will put bureaucrats in charge of health care decisions that should be made by families and doctors." He added, "It will limit treatment options and lead to rationed care," and "to pay for government health care, your taxes will be raised." Boustany, a member of the House Republican Health Care Solutions Group, said, "That is something we cannot support, and frankly, it would clearly violate some of the principles the president himself has endorsed" (Superville, AP/Washington Post, 5/16). In related news, Office of Management and Budget Director Peter Orszag on Sunday said on CNN"s "State of the Union" that the administration might support taxing health care benefits to health pay for health care reform (Barr, Politico, 5/17). Timeline
generic viagra online
5-Year Study Published In Diabetologia Demonstrated Long-Term Safety Of Lantus(R) Compared To NPH
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that the results of the long-term, 5-year study of Lantus(R) (insulin glargine [rDNA] injection) versus NPH insulin on progression of retinopathy in patients with type 2 diabetes, published on-line in Diabetologia (DOI 10.1007/s00125-009-1415-7) showed similar effects on retinopathy and overall safety in the two treatment groups. This is the longest controlled study ever reported using insulin glargine.
plastic surgery before after
News of the day
Less Sleep Associated With High, Worsening Blood Pressure In Middle Age
Middle-aged adults who sleep fewer hours appear more likely to have high blood pressure and to experience adverse changes in blood pressure over time, according to a report in the June 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Public Health

University Of Kentucky's Markey Cancer Center Brings Advanced TomoTherapySM Treatment Technology To Brain And Body Radiosurgery Program

TomoTherapy Incorporated (NASDAQ: TOMO) announced that the University of Kentucky (UK) Chandler Medical Center"s Markey Cancer Center has commenced treating patients with the TomoTherapy® Hiò€¢Art® treatment system, a versatile, CT scanner-based device, which integrates image guidance for increased treatment accuracy and helical radiation therapy delivery for enhanced tumor targeting. The Hiò€¢Art treatment system was selected after a thorough review of technologies and will be extensively utilized in the Markey Cancer Center"s stereotactic body radiation therapy (SBRT) efforts, as part of its new Brain and Body Radiosurgery Program. Marcus E. Randall, M.D., professor and chair of the Department of Radiation Medicine at the UK College of Medicine, serves as director of the Brain and Body Radiosurgery Program. According to Dr. Randall, TomoTherapy technology was a natural choice. "We were looking for a platform that would permit exceptionally accurate treatments while allowing for reasonable throughput of patients," said Dr. Randall. "We considered all our options, including RapidArc™ and Cyberknife®, but we felt that the dose distributions from TomoTherapy were consistently superior to other platforms. The ability to do imaging at the time of treatment was also a unique advantage, so the decision actually became pretty simple." SBRT: A New Focus in Cancer Care SBRT is a noninvasive technique that precisely delivers high doses of radiation to a tumor, while minimizing damage to surrounding healthy tissues. In addition to growing evidence that this technique may be radiobiologically more effective for certain types of cancer cases, SBRT offers cancer centers the ability to treat more patients over a shorter, more convenient treatment schedule, requiring five or fewer treatments. Traditional radiation therapy, because a lower dose of radiation is delivered in each session, can require 20-40 treatments over a four to eight week period. Ronald McGarry, M.D., Ph.D., clinical associate professor and vice chair of the Department of Radiation Medicine at the UK College of Medicine, helped pioneer SBRT as a technique and has many years of experience with this advanced treatment approach. He believes the TomoTherapy platform offers specific advantages for cancer patients, including: the ability to reduce treatment times; track treatment progress via daily CT imaging and adapt the plan, if necessary; and potentially reduce treatment toxicity when critical organs are at risk. "The biggest gain to our department is the conformal radiation plans that helical intensity-modulated radiation therapy (IMRT) allows us to do," said Dr. McGarry. "We will also be pursuing adaptive radiation therapy using the CT guidance of TomoTherapy. Certainly, this is an advantage of the platform. For SBRT use, our main targets of interest for Tomo® will be spine, liver and prostate. Spine and prostate will be the subject of clinical trials in our department, and we are opening a spinal SBRT protocol which will largely be carried out using TomoTherapy technology." First TomoTherapy Hiò€¢Art Treatment System in Lexington The TomoTherapy Hiò€¢Art treatment system at Markey Cancer Center is the first to be installed in Lexington and the second in the state of Kentucky, which is ranked fourth nationwide in overall cancer incidence and has a significantly higher cancer mortality rate than the national average. "TomoTherapy is honored to have been chosen to improve cancer patient care in Kentucky," said Ralph Vaello, vice president of global sales for TomoTherapy Incorporated. "We are pleased to be playing an integral part in the Markey Cancer Center"s newly launched Brain and Body Radiosurgery Program. Endorsement by this program and by Dr. Randall and Dr. McGarry-pioneers in their field-further validates TomoTherapy as the platform of the future, designed to meet the widest range of advanced radiotherapy needs." About the Markey Cancer Center The Markey Cancer Center is a premier cancer research and patient care facility that utilizes the res of 28 departments, 8 colleges and 150 faculty throughout UK HealthCare to further the prevention, treatment and cure of cancer. To learn more, please visit here. TomoTherapy Incorporated


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009